accountGlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety data about a diabetes drug.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlement
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account